Weekly Recap | Vertex Pharma -5.62%, low-volume pullback lags the S&P 500Weekly Review·Sep 12 at 07:06 AMVRTX-0.29%
Weekly Recap | Twist Bioscience +2%, consensus target below spotWeekly Review·Sep 12 at 07:00 AMTWST+2.34%
Weekly Recap | Revolution Medicines -2.98%, consensus target above spotWeekly Review·Sep 12 at 06:40 AMRVMD-4.12%
Weekly Recap | Regeneron Pharma -5.59%, class action deadline passesWeekly Review·Sep 12 at 06:39 AMREGN+0.10%
Weekly Recap | Moderna -1.09%, tumour vaccine milestoneWeekly Review·Sep 12 at 06:22 AMMRNA+0.29%MRNY+0.32%
Weekly Recap | Twist Bioscience -11.78%, giving back prior gainsWeekly Review·Sep 5 at 08:18 AMTWST+2.34%
Weekly Recap | Revolution Medicines +1.03%, RASONQUE data takes centre stageWeekly Review·Sep 5 at 08:03 AMRVMD-4.12%
Weekly Recap | Regeneron Pharma +4.22%, closing in on record highsWeekly Review·Sep 5 at 07:49 AMREGN+0.10%
Weekly Recap | Moderna +5.48%, consensus target below spotWeekly Review·Sep 5 at 07:36 AMMRNA+0.29%MRNY+0.32%
Weekly Recap | Twist Bioscience -2.89%, most brokers rate it buyWeekly Review·Aug 29 at 06:36 AMTWST+2.34%
Weekly Recap | Revolution Medicines -0.75%, most brokers rate it buyWeekly Review·Aug 29 at 06:22 AMRVMD-4.12%
Weekly Recap | Regeneron Pharma -4.78%, consensus target above spotWeekly Review·Aug 29 at 06:22 AMREGN+0.10%
Weekly Recap | Moderna -4.92%, convertible offering weighsWeekly Review·Aug 29 at 06:02 AMMRNA+0.29%MRNY+0.32%
Weekly Recap | Twist Bioscience +22.79%, AI deal sparks 52-week highWeekly Review·Aug 22 at 05:41 AMTWST+2.34%
